Seminars in Arthritis and Rheumatism

Papers
(The H4-Index of Seminars in Arthritis and Rheumatism is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities127
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis116
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review97
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies95
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 202070
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States63
Antisynthetase syndrome – much more than just a myopathy62
Axial involvement in psoriatic arthritis: An update for rheumatologists59
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review57
What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review56
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems55
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis54
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO regi50
The ASAS-OMERACT core domain set for axial spondyloarthritis49
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data48
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review41
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time39
The economic burden of fibromyalgia: A systematic literature review39
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study38
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial35
The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis35
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study34
Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis34
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis34
Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis33
The prevalence of gout and hyperuricaemia in Australia: An updated systematic review33
Management of calcium pyrophosphate crystal deposition disease: A systematic review32
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience31
Immunopathogenesis of Behçet's disease and treatment modalities30
Gut microbiota changes in patients with spondyloarthritis: A systematic review30
0.058548927307129